Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-21
DOI
10.1038/srep15460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
- (2014) Yanqiong Liu et al. BMC Medicine
- Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer
- (2014) S. A. Streicher et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force
- (2013) Tracy Wolff ANNALS OF INTERNAL MEDICINE
- The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer
- (2013) Paolo G. Gobbi et al. Cancer Epidemiology
- High-Dose Aspirin Consumption Contributes to Decreased Risk for Pancreatic Cancer in a Systematic Review and Meta-analysis
- (2013) Xi-Jun Cui et al. PANCREAS
- Daily Aspirin Use and Cancer Mortality in a Large US Cohort
- (2012) E. J. Jacobs et al. JNCI-Journal of the National Cancer Institute
- Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case-Control Study
- (2011) X.-L. Tan et al. Cancer Prevention Research
- Meta-Analysis on the Association Between Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Risk
- (2011) Jiali Xu et al. Clinical Lung Cancer
- Aspirin, NSAIDS, Calcium-channel blockers and statins in the aetiology of pancreatic cancer: preliminary results from a case-control study in two centres in the UK
- (2011) T. F. G. Pugh et al. GUT
- Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study
- (2010) M C Bradley et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aspirin use and pancreatic cancer risk
- (2010) Martina Bonifazi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
- (2009) C C Abnet et al. BRITISH JOURNAL OF CANCER
- Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
- (2009) Bernard F. Cole et al. JNCI-Journal of the National Cancer Institute
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis
- (2008) Jennifer Permuth-Wey et al. Familial Cancer
- Randomized Clinical Trials and Observational Studies
- (2008) Edward L. Hannan JACC-Cardiovascular Interventions
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started